USPOREDBA GENERIČKIH I ORIGINALNIH ANTIGLAUKOMSKIH LiJEKOVA U SPLITSKO-DALMATINSKOJ ŽUPANIJI
Autor: | Mastnak, Viktor Marin |
---|---|
Přispěvatelé: | Rogošić, Veljko, Božić, Joško, Ivanišević, Milan, Znaor, Ljubo |
Jazyk: | angličtina |
Rok vydání: | 2017 |
Předmět: | |
Popis: | Aim of the thesis: The primary aim of this research in medical anti-glaucoma therapy is to find out the total number of anti-glaucoma drugs in Split-Dalmatia county in the last 5 years, especially with regards to consumption of original anti-glaucoma drugs against their generic counterparts and comparison between fixed (combined) and mono therapy. Also we want to show if the prescription of prostaglandin analogues has risen through the years. Patients and methods: In this research we used data of the number of anti-glaucoma drugs used in Split- Dalmatia County between the years of 2012 and 2016 from glaucoma patients. The data is collected in pharmacies of the county. In this research the data gathered from the pharmacies have been retrospectively statistically and analytically analysed. The data was processed in Microsoft Excel and Microsoft Word programs. In the processing of the data we used the Pearson correlation coefficient. The results were interpreted at a significance level of p Cilj istraživanja: Primarni cilj ovog istraživanja je istražiti ukupan broj antiglaukomskih lijekova (AGL) u Splitsko-dalmatinskoj županiji u zadnjih 5 godina (2012. - 2016.), pogotovo usporedba konzumiranih originalnih antiglaukomskih lijekova sa genericima, zatim usporedbu između fiksne antiglaukomske terapije i monoterapije, te da li je porastao broj prodanih analoga prostaglandina/prostamida kroz 2012. - 2016. god. Ispitanici i metode: Za izradu ovog istraživanja bilo je nužno prikupiti podatke o broju potrošnji antiglaukomskih lijekova od 2012. do 2016. godine na području Splitsko-dalmatinske županije. U obradi podataka smo koristili Pearson koeficijenta korelacije. Podaci su interpretirani na razini značajnosti p |
Databáze: | OpenAIRE |
Externí odkaz: |